Get started
Author

Theresa Pattery

Induction of Systemic Resistance to Botrytis cinerea in Tomato by Pseudomonas aeruginosa 7NSK2: Role of Salicylic Acid, Pyochelin, and Pyocyanin
2002 · Kris Audenaert, Theresa Pattery, et al. · Molecular Plant-Microbe Interactions · 393
PDF
Pyocyanin Production by Pseudomonas aeruginosa Induces Neutrophil Apoptosis and Impairs Neutrophil-Mediated Host Defenses In Vivo
2005 · Lucy Allen, David H Dockrell, et al. · The Journal of Immunology · 255
Identification of type II and type III pyoverdine receptors from Pseudomonas aeruginosa
2003 · Magaly de Chial, Bart Ghysels, et al. · Microbiology · 100
PDF
Broad Phenotypic Cross-Resistance to Elvitegravir in HIV-Infected Patients Failing on Raltegravir-Containing Regimens
2012 · Carolina Garrido, Jorge Villacian, et al. · Antimicrobial Agents and Chemotherapy · 65
Identification and molecular characterization of a novel Salmonella enteritidis pathogenicity islet encoding an ABC transporter
1999 · Theresa Pattery, Jean‐Pierre Hernalsteens, et al. · Molecular Microbiology · 46
Rare mutations at codon 103 of HIV-1 reverse transcriptase can confer resistance to non-nucleoside reverse transcriptase inhibitors
2005 · P Richard Harrigan, Theresa Mo, et al. · AIDS · 40
Prevalence of the HIV-1 protease mutation I47A in clinical practice and association with lopinavir resistance
2006 · Carmen de Mendoza, Luisa Valer, et al. · AIDS · 35
Phenotypic impact of resistance mutations on etravirine susceptibility in HIV patients with prior failure to nonnucleoside analogues
2008 · Eva Poveda, Carmen de Mendoza, et al. · AIDS · 33
A comparison of HIV‐1 drug susceptibility as provided by conventional phenotyping and by a phenotype prediction tool based on viral genotype
2009 · Margriet Van Houtte, Gaston Picchio, et al. · Journal of Medical Virology · 31
Impact of mutations in hemA and hemH genes on pyoverdine production by Pseudomonas fluorescens ATCC17400
2001 · Christine Baysse, Sandra Matthijs, et al. · FEMS Microbiology Letters · 29
Digital health technology used in emergency large-scale vaccination campaigns in low- and middle-income countries: a narrative review for improved pandemic preparedness
2023 · Paula Mc Kenna, Lindsay A. Broadfield, et al. · Expert Review of Vaccines · 21
PDF
Development and Performance of Conventional HIV-1 Phenotyping (Antivirogram®) and Genotype-Based Calculated Phenotyping Assay (virco®TYPE HIV-1) on Protease and Reverse Transcriptase Genes to Evaluate Drug Resistance
2012 · Theresa Pattery, Yvan Verlinden, et al. · Intervirology · 21
The HIV-1 protease resistance mutation I50L is associated with resistance to atazanavir and susceptibility to other protease inhibitors in multiple mutational contexts
2008 · P. Sista, B. Wasikowski, et al. · Journal of Clinical Virology · 21
Comparative Analysis of Drug Resistance Among B and the Most Prevalent Non-B HIV Type 1 Subtypes (C, F, and CRF02_AG) in Italy
2012 · Maria Mercedes Santoro, Claudia Alteri, et al. · AIDS Research and Human Retroviruses · 20
The Impact of Individual Human Immunodeficiency Virus Type 1 Protease Mutations on Drug Susceptibility Is Highly Influenced by Complex Interactions with the Background Protease Sequence
2009 · H. Van Marck, I. Dierynck, et al. · Journal of Virology · 20
Amplification and Sequencing of the Hepatitis C Virus NS3/4A Protease and the NS5B Polymerase Regions for Genotypic Resistance Detection of Clinical Isolates of Subtypes 1a and 1b
2013 · Diana Koletzki, Theresa Pattery, et al. · Methods in molecular biology · 17
Rapid accumulation of HIV-1 thymidine analogue mutations and phenotypic impact following prolonged viral failure on zidovudine-based first-line ART in sub-Saharan Africa
2016 · Ruth L. Goodall, David T. Dunn, et al. · Journal of Antimicrobial Chemotherapy · 16
PDF
Additional HIV-1 mutation patterns associated with reduced phenotypic susceptibility to etravirine in clinical samples
2009 · Ron M Kagan, Prakash Sista, et al. · AIDS · 15
Development, Evaluation, and Integration of a Quantitative Reverse-Transcription Polymerase Chain Reaction Diagnostic Test for Ebola Virus on a Molecular Diagnostics Platform
2016 · Lieselotte Cnops, Peter Van den Eede, et al. · The Journal of Infectious Diseases · 13
PDF
HIV-1 nucleotide mixture detection in the virco®TYPE HIV-1 genotyping assay: A comparison between Sanger sequencing and 454 pyrosequencing
2011 · Hans De Wolf, Herwig Van Marck, et al. · Journal of Virological Methods · 13
Risk factors for raltegravir resistance development in clinical practice
2012 · I. Malet, S. Fourati, et al. · Journal of Antimicrobial Chemotherapy · 12
Novel Drug Resistance Pattern Associated with the Mutations K70G and M184V in Human Immunodeficiency Virus Type 1 Reverse Transcriptase
2007 · D. Bradshaw, S. Malik, et al. · Antimicrobial Agents and Chemotherapy · 11
Nine-year trends in clinically relevant reduced susceptibility of HIV-1 to antiretrovirals
2009 · P. Sista, A. Rinehart, et al. · Journal of Clinical Virology · 10
Impact of a pilot mHealth intervention on treatment outcomes of TB patients seeking care in the private sector using Propensity Scores Matching—Evidence collated from New Delhi, India
2024 · Ridhima Sodhi, Vindhya Vatsyayan, et al. · PLOS Digital Health · 9
PDF
Comparison of the Idylla™ Respiratory (IFV-RSV) panel with the GeneXpert Xpert® Flu/RSV assay: a retrospective study with nasopharyngeal and midturbinate samples
2018 · Yannick Wouters, Els Keyaerts, et al. · Diagnostic Microbiology and Infectious Disease · 8
Works count: 52
Citation count: 1,310
H-index: 16
I10-index: 23
Year
Topic
Type